Next Article in Journal
In-Situ Catalytic Fast Pyrolysis of Pinecone over HY Catalysts
Previous Article in Journal
Biodiesel at the Crossroads: A Critical Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Genipin as An Emergent Tool in the Design of Biocatalysts: Mechanism of Reaction and Applications

by
Veymar G. Tacias-Pascacio
1,
Esmeralda García-Parra
1,
Gilber Vela-Gutiérrez
1,
Jose J. Virgen-Ortiz
2,
Ángel Berenguer-Murcia
3,
Andrés R. Alcántara
4 and
Roberto Fernandez-Lafuente
5,*
1
Facultad de Ciencias de la Nutrición y Alimentos, Universidad de Ciencias y Artes de Chiapas, 29050 Chiapas, Mexico
2
CONACYT—Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD)—CIDAM, Km. 8 Antigua Carretera a Pátzcuaro s/n, 58341 Morelia, Mexico
3
Departamento de Química Inorgánica e Instituto Universitario de Materiales, Universidad de Alicante, 03080 Alicante, Spain
4
Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain
5
Departamento de Biocatálisis, ICP-CSIC, Campus UAM-CSIC, 28049 Madrid, Spain
*
Author to whom correspondence should be addressed.
Submission received: 18 November 2019 / Revised: 29 November 2019 / Accepted: 5 December 2019 / Published: 6 December 2019
(This article belongs to the Section Biocatalysis)

Abstract

:
Genipin is a reagent isolated from the Gardenia jasminoides fruit extract, and whose low toxicity and good crosslinking properties have converted it into a reactive whose popularity is increasing by the day. These properties have made it widely used in many medical applications, mainly in the production of chitosan materials (crosslinked by this reactive), biological scaffolds for tissue engineering, and nanoparticles of chitosan and nanogels of proteins for controlled drug delivery, the genipin crosslinking being a key point to strengthen the stability of these materials. This review is focused on the mechanism of reaction of this reagent and its use in the design of biocatalysts, where genipin plays a double role, as a support activating agent and as inter- or intramolecular crosslinker. Its low toxicity makes this compound an ideal alterative to glutaraldehyde in these processes. Moreover, in some cases the features of the biocatalysts prepared using genipin surpassed those of the biocatalysts prepared using other standard crosslinkers, even disregarding toxicity. In this way, genipin is a very promising reagent in the design of biocatalysts.

1. Introduction

1.1. Biocatalysis and Biocatalysts Design

The relevance of enzymatic biocatalysis is continuously growing due to the advantages of enzymes: very high activity, selectivity and specificity under environmentally friendly conditions [1,2,3]. Thus, they become very suitable from the point of view of green chemistry and atomic economy [4,5,6,7]. However, enzymes have these very good properties in their physiological function and reaction medium, in many instances very different from the ones where they may have industrial interest [8,9,10]. From this perspective, in most cases, enzyme properties need to be improved before their implementation. Nowadays, this may be reached by using very diverse strategies. Metagenomics [11,12,13,14] permit the use of any enzyme, even belonging to a non-cultivable organism or a no longer existing one, making the quest for suitable enzymes within reach since it permits the use of all past and present biodiversity. Genetic tools like site-directed mutagenesis or directed evolution [9,15,16,17,18] permit to further improve enzyme properties. These features may be further improved by physicochemical tools. Chemical modification of enzymes has been utilized to alter the physical properties of the enzyme surface and, thus, alter their properties, or to introduce inter- or intramolecular chemical crosslinkings, to increase the rigidity of the enzyme structure and its stability, or to prevent the dissociation of multimeric enzymes [19,20,21,22,23]. Coating of the enzyme surface with polymers prevents proteolysis and interaction with external interfaces (e.g., drops of solvents or gas bubbles) [24,25,26]. Physical crosslinking with ionic polymers has also proved to be effective in the stabilization of multimeric enzymes and in the prevention of interactions with external interfaces [27]. Enzyme immobilization was firstly developed to permit the reuse of enzymes, which are soluble molecules [28,29]. Currently, an immobilization protocol should be valid to improve some enzyme properties. Stabilization may be accomplished via multipoint covalent attachment [30]; multimeric enzymes may be stabilized via multisubunit immobilization that avoids subunit dissociation, in some instances the microenvironment generated around the immobilized enzyme molecule can have some positive effects on its stability (e.g., partitioning some deleterious reagents, like hydrogen peroxide, oxygen or organic solvents) [31,32,33]. In other cases, enzyme activity may be improved, in some instances by fixing more active enzyme conformations (e.g., the case of lipases interfacially activated versus hydrophobic supports), in others by making more resilient enzymes under the measurement conditions. These effects of immobilization on enzyme activity have been reviewed [34,35,36,37,38,39,40,41]. Immobilization may also improve enzyme selectivity or/and selectivity in the industrially-targeted process, reduce enzyme inhibition, increase enzyme purity, etc. [42]. As a result, immobilization is nowadays not a tool to reuse enzymes, and remains as a very important step in most biocatalytic processes, even if in some instances the price of the enzyme may seem low enough. Immobilization can be coupled to any of the other strategies to get a more suitable enzyme, as they can be used all together. In fact, there are some cases where genetic or chemical modifications have been designed to improve enzyme immobilization more than the features of the soluble enzyme [43].
This review will focus on the use of these physicochemical tools to improve enzyme features. In enzyme immobilization, a critical step is the selection of a suitable support and immobilization protocol. There are many immobilization protocols but only some selected few are suitable for taking full advantage of the immobilization (i.e., permitting an intense multipoint covalent attachment). Glyoxyl supports have proved to be able to give very intense multipoint covalent attachment involving primary amino groups of a protein, but they need to be used at pH 10 to exploit this advantage and a final reduction with sodium borohydride is required, making the method difficult to implement [44,45,46]. Epichlorohydrin and some di-epoxides may be used to activate supports with epoxy groups, this group may react with many different groups of a protein but at a low reaction rate, making them interesting but not ideal ones, although some heterofunctional supports have given good results [47,48,49]. Divinylsulfone has been recently recognized as a very suitable support activator, that permits very intense multipoint covalent attachment, but it is relatively toxic [50,51,52]. Glutaraldehyde is perhaps the most utilized reagent for enzyme immobilization, as it can react with primary amino groups located in a support and the resulting supports have low capability to react with the primary amino groups of a protein [53]. Although the exact mechanism of action of glutaraldehyde is not fully understood, this method is very versatile and permits very different immobilization protocols, in many instances with significant stabilizing effects [54,55,56,57]. Glutaraldehyde is also the most used reagent to introduce enzyme intermolecular crosslinkings [54,58,59]. However, the FDA does no longer permit its use. That way there is a great interest in using alternative support activating and crosslinking reagents.

1.2. Genipin Uses

In this context, genipin (Figure 1) has attracted the interest of researchers worldwide. This natural compound has many uses. For example, it is used as intermediate for the synthesis of some alkaloids [60,61]. It has been found in Gardenia jasminoides fruit extract and has good crosslinking properties [62,63], while its acute toxicity is low [64,65,66], Thus is the reason for that makes genipin having a growing number of uses and applications. Genipin (methyl 1-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta [c]pyran-4-carboxylate, Figure 1) is a colorless iridoid (cyclopentapyrane-type monoterpenoid) obtained via the enzymatic hydrolysis of geniposide, one of the primary active principles contained in the fruit of Gardenia jasminoides.

2. Chemisty of Genipin

Genipin reacts with primary and secondary amines; this reaction is very useful for polymer chemistry and in many other biological applications, because its biodegradability and low toxicity make genipin an excellent reagent for cross-linking processes [67].
In spite of the high industrial applicability of genipin and the great number of processes in which it has been used, a full characterization of its structure has not been available until recently [68,69]. In fact, the structure of genipin in solid state was described by Trevor et al. (2008), assigning the absolute configuration of the three sterocentres of the molecule as 1S, 4aR, 7aR [70]. Di Tommaso et al. (2013) reported a detailed study (using 1H-NMR and corroborated by computational chemistry) of the structure of genipin in solution at different pH values [68]. These authors described that at highly alkaline pH values (around 13) genipin is not stable and undergoes self-polymerization; while in slightly alkaline medium (pH = 8) 1H-NMR signals indicate the existence of a single compound in which both rings are fused following a cis stereochemistry. This confirms the previously reported stereochemistry 1S, 4aR, 7aR [70] (1, Figure 2), although also the possible enantiomer ent-1 could obviously produce the same signals.
In acidic medium (pH = 3.6, measured in D2O/DCl), a second isomer form of genipin is detected, albeit at low concentration. This minor compound is characterized by a two cis coupling constants, between the two protons linked to carbons 4a and 7a, and between the protons linked to carbon 7a and 1. Therefore, this fact is pointing towards the presence of a structure such as 3, possessing the absolute configuration 1R, 4aR, 7aR, or its enantiomer ent-3. Some other possible cyclic stereoisomers such as 7 or 8 (Figure 2) were not detected. These results were ratified by molecular modeling, confirming that isomer 1 (or ent-1) are more stable than 3 (or ent-3), also establishing the most stable conformation (two half chairs) of 1 (denoted as up), in which carbon 1 is out-of-plane with respect to the plane defined by the chain bond to chiral center 4a (atoms 4, 3, 2). This up conformation is 4 kcal mol−1 more stable than the corresponding in-plane down conformation.
These authors also performed a study with the aim of understanding the opening mechanism of the cyclic structure of genipin 1 in solution leading to dialdehyde 4. Thus, they separately studied the energy barriers needed in the transformation of 1 into 2, and from 2 into 4, as depicted in Figure 3.
The first step involves an intramolecular hydrogen transfer first through a four-membered ring transition state TS1-2 (Figure 3), leading to the intermediate 2, possessing a carbonyl and an enol moieties. This process is thermodynamically disfavored, as it is endothermic by about 15 kcal mol−1, also requiring a very high activation barrier of about 48 kcal mol−1. Nevertheless, if the contribution of one (six-members ring TS1-2(H2O)) or two (eight-members ring TS1-2(H2O)2) is considered, as shown in Figure 4, the activation energy drops to about 29 and 17 kcal mol−1, respectively, due to the decrease of the ring strain. In addition, the process becomes less endothermic (5.6 kcal mol−1) when two molecules of water are added [68].
Similarly, the conversion of 2 into 4 via transition state TS2-4 (Figure 3) was also modelled [68], reporting an activation enthalpy of 60 kcal mol−1 (no water involved) which is reduced to 22.3 kcal mol−1 when two water molecules are involved. On the other hand, the endothermicity of the reaction increased from −4 (no water) up to −2 kcal mol−1 (2 explicit water molecules). Remarkably, for the conversion of 2 into 4 the activation barrier decreased down to 16.5 kcal mol−1 when considering the presence of a solvent shell (ethanol was simulated by a continuum) and two water molecules. This is contrary to what was observed for TS1-2, where the contribution of solvation (0.2 kcal mol−1 on the barrier and 0.6 kcal mol−1 for the product stability) was almost negligible.

Reactivity of Genipin as Cross-Linker Agent

Fujikawa et al. (1998) described the formation of dimers of genipin in the presence of glycine [71]. This fact opened the door for promoting the use of genipin for covalently crosslinking of proteins containing residues with primary amine groups [67,72]. The mechanism for this crosslinking is not clear yet, and different hypotheses have been proposed; thus, Butler et al. (2003) by studying the reaction between chitosan (biopolymer naturally containing primary amine groups), bovine serum albumin (BSA), and gelatin with genipin [73], proposed a mechanism depicted in Figure 5.
The initial step was suggested to be the nucleophilic attack of one amine group from the biopolymer (in red) to α, β-insaturated ester, with the corresponding opening to yield 19, in a similar way as postulated by Touyama [74] (Figure 5, Mechanism B). In the second step, another amine group from the biopolymer (in blue) will attack the methoxycarbonyl group to produce a secondary amide-type linkage, with the concomitant release of methanol, to produce the crosslinked compound 20. As commented in the section before, according to Di Tomasso et al. [68,69] probably the first step would alternatively proceed via a previous opening of the hemiacetal 1 to the dialdehyde 4, which will be attacked by the amino group in red of the biopolymer to furnish 20.
More recently, Dimida et al. (2015) reported a study of the crosslinking of chitosan with genipin by means of calorimetric analyses (differential scanning calorimetry) and swelling measurements at different pHs and ionic strength, while the reaction kinetics were determined by rheological measurements [75]. These authors supported the cross-linking mechanism depicted in Figure 5, under mild acidic or neutral conditions; some other papers are also bolster this mechanism [76,77].
Another different crosslinking pathway was also considered in the manuscript from Dimida et al. [75], based on the previous work of Fujikawa et al. [71,78], which reported the structure of Genipocyanin G1 (Figure 6, 20), the main product of the reaction between genipin and glycine. These authors did not propose a mechanism for the dimerization, but rather suggested that a radical mechanism might be responsible for the C-C linkage between pentagonal rings of the genipin moieties [78]; thus, they proposed a similar mechanism for yielding the cross-linked structure 21 (Figure 6). This structure has been assumed in the literature [72,75,79,80,81,82], although in the original papers from Touyama et al. [74,83], which systematically described the nature of the species produced upon dimerization (or trimerization) of genipin subunits; this type of structure possessing a methylidine linkage between both pentagonal rings was never reported, while some other ones were described.
It is important to note that, independently from the precise nature of the chemical bonds involved in the crosslinking, genipin is undoubtedly a very useful, non-toxic, and green reagent for the generation of cross-linked biomaterials [67,72,75,77,84,85,86,87].

3. Use of Genipin in Biocatalysts Design

Based in the chemistry described above, it is possible to establish how genipin may be used in the preparation of biocatalysts, which kind of reactions will occur (even if they are still under debate) and the groups in support and protein that may become involved in the modification.

3.1. General Aspects of Use of Genipin in Enzyme Immobilization

Genipin has found some interesting uses in enzyme immobilization, mainly due to its low toxicity [88], but also to its good crosslinking features [89]. These pioneering immobilization studies have been performed without really understanding the reaction mechanisms of genipin (see the section above). Thus, it is very likely that the full potential of this reagent is still far from the maximum.
Moreover, it should be considered that in most immobilization cases, when a pre-existing support is used, it tends to be a matrix presenting primary amino groups. That way genipin-activated supports may be considered a heterofunctional support (Figure 7). The first step of the enzyme immobilization on the support may be via covalent immobilization, via anion exchange or via hydrophobic interactions with the layer of genipin. It needs to be considered that the support will be never physically inert, as in the case of using aminated supports and glutaraldehyde [90]. To the best of our knowledge, the versatility of aminated supports activated with genipin has not been adequately exploited, but we have found many different ways of using genipin in enzyme immobilization (activating the support (Figure 8), treating previously immobilized enzymes (Figure 9) or even mixing support, enzyme, and genipin in one step (Figure 10). Next, we present the most relevant papers related to the use of this reagent in enzyme immobilization.

3.2. Enzyme Immobilization on Preexisting Supports Using Genipin

In an initial work using genipin to prepare an immobilized enzyme biocatalyst, the role of genipin was to crosslink enzymes trapped in alginate and, that way, prevent enzyme release. A β-glucosidase was immobilized on calcium alginate, but the leakage was very high [91]. To prevent this, the trapped enzyme was treated with different crosslinking agents (glutaraldehyde; 1-ethyl-3-(3-dimethylaminopropyl) cardodiimide, N-hydroxysuccinimide and genipin). Genipin was the most effective in preventing enzyme leaching, enabling 12 repeated uses without significant activity decrease, while with the other crosslinkers a significant enzyme inactivation could be found [91].
In another research effort, lipase from Candida sp. 99-125 was immobilized on two different resins comparing genipin and glutaraldehyde as crosslinker agents [92]. It was found that the immobilized enzyme using genipin exhibited higher storage, pH, and thermal stabilities than the immobilized enzyme using glutaraldehyde. This also resulted in the operational stability being higher using genipin (over 60% of residual activity in the sixth cycle when using genipin while only 35% was attained when using glutaraldehyde) [92]. The same group subsequently reported the immobilization of the same enzyme in a resin, which after immobilization was treated with genipin to obtain covalent attachments (Figure 9). The operational stability of the biocatalyst was quite good, enabling 50 reuses with conversions remaining over 90%.
Chitosan primary amino groups have been used in many instances to immobilize proteins [93], and it has also been used in many cases coupled to genipin to covalently immobilize enzymes (Figure 7). For example, chitosan beads and genipin were utilized to immobilize a lipase [94]. The immobilized enzyme was more active than the free enzyme and resulted in a suitable stabilization at drastic pH values or high temperatures. In another paper, a xylanase was immobilized on magnetic chitosan nanoparticles using genipin to get chitosan-enzyme covalent bonds (apparently mixing genipin, chitosan nanoparticles, and xylanase in one step) [95]. Immobilized xylanase exhibited a higher optimal temperature and broader range of pH where enzyme activity was significantly higher than the free enzyme. However, the operational stability was unsatisfactory [95]. Another publication shows how a purified laccase from Trametes pubescens was entrapped in chitosan beads pre-activated with genipin. The immobilization increased enzyme stability under many inactivation conditions, and the resulting biocatalyst decolorized structurally different synthetic dyes without oxidizing mediators [88]. In another research effort, laccase was immobilized on a matrix formed by chitosan crosslinked with genipin and used as a biosensor [96]. The biosensor was utilized in the determination of the total phenolic content of mated herb samples.
Rangel-Rodríguez et al. (2014), reported the crosslinking of chitosan membranes with genipin and used to immobilize fungal pectin esterase. This biocatalyst was successfully used to transform highly-methoxylated pectins into lowly-methoxylated pectins [97]. In another paper, the β-d-galactosidase from Aspergillus oryzae was immobilized on chitosan particles followed by treatment with genipin [98]. In this case, the biocatalysts were successfully applied to the production of galacto-oligosaccharides and lactose hydrolysis, maintaining their activity after 25 batches of lactose hydrolysis. The authors classified this biocatalyst as food grade [98].
Using as model the β-galactosidase from Aspergillus oryzae, the parameters defining the activation of chitosan has been recently analyzed [89]. The effects of genipin concentration (2.5 mg mL−1), temperature (60 °C), pH (pH 9), and reaction time (1 h) were evaluated in the support activation. The immobilized enzyme was two-fold more stable than the free enzyme, and the authors advance likely structures of genipin in the reaction with chitosan [89].
In some instances, the results achieved in the biocatalyst performance after chitosan activation with genipin were compared with those obtained using other reagents. For example, chitosan beads activated with glutaraldehyde or genipin were used to immobilize a keratinase from Purpureocillium lilacinum LPSC #876 [99]. Immobilization yield was similar using both reagents, but expressed activity was higher using genipin. This biocatalyst showed enhanced stability (at drastic pH values or high temperatures) and retained more than 60% of its initial value after five hydrolytic cycles [99]. In another paper, lipase from Candida rugosa was immobilized on chitosan encapsulated magnetic nanoparticles using glutaraldehyde or genipin [100]. Genipin permitted to prepare the biocatalysts with the best performance; for example, after five reaction cycles, the biocatalyst prepared using glutaraldehyde exhibited only 26% of its initial activity while the one prepared using genipin maintained over 80%. In fact, this biocatalyst was more stable under drastic pH and temperature, and also presented better operational stabilities than the one prepared using glutaraldehyde [100].
In another paper, commercial β-glucosidase was immobilized by mixing it with chitosan beads and genipin [101]. The biocatalysts beads improved their resistance under acidic conditions after crosslinking. When using the traditional glutaraldehyde immobilization (preactivating the support) (Figure 7 and Figure 8), the activity recovery was lower and the immobilization protocol was longer. The genipin-immobilized enzyme was also more stable than the free or the glutaraldehyde-immobilized enzyme. This biocatalyst was applied to hydrolyze genistin to genistein, maintaining 85% of conversion after 5 cycles [101].
It is important to mention that genipin is not always the reagent that offers the best results. For example, acidic proteases from Monterey sardine stomachs were immobilized onto chitin flakes using genipin or Na-tripolyphosphate with similar (good) performance; the authors reported a great importance on the deacetylation degree of chitosan more than on the chemical reagent [102]. In another example, polyethyleneimine was fixed on a chitin film using epichlorohydrin, glutaraldehyde or genipin [103]. Laccase was then immobilized on the modified film, as polyethylenimine is a very good ion exchanger. In this instance, epichlorohydrin was the crosslinker reagent that gave the best results [24]. Other authors report the immobilization of cytosine arabinoside on bacterial magnetosomes just physically adsorbed or using some crosslinkers, finding that the best loading was achieved using direct adsorption [104].
It should be considered anyway that in these papers, the versatility of glutaraldehyde was not applied to obtain the most active and stable biocatalyst [53,105,106,107,108,109]. The same situation occurs with the genipin, since generally only one condition is used (Figure 7). In that way, it is likely that the genipin potential in enzyme immobilization is still undervalued.
In some other cases, genipin was used in the production of the support. For example, superparamagnetic carboxymethyl chitosan nanospheres were successfully synthesized using genipin as a cross-linking agent of the chitosan [110]. These nano-spheres were then used to immobilize lysozyme.
In other cases, the objective was not to have an irreversibly immobilized enzyme, but to control the way the enzyme is leakage from the support, as enzyme deliverable system. For example, gelatin films were treated using genipin and used to trap lysozyme in a way that they could be released to prevent microbial contamination [111]. Non-crosslinked gelatin films are too unstable, mainly in high humidity environments, for this use. Genipin crosslinked films reduced the lysozyme release at pH 7.0 but not at pH 3.8. On the other hand, antimicrobial activity of the lysozyme-films decreased when genipin concentration increased, indicating too slow an enzyme release. The authors claimed that these films were able to prolong the antimicrobial effects of lysozyme during food storage, increasing food safety [111]. Later, another research group also prepared gelatin films crosslinked with genipin to immobilize lysozyme analyzing the swelling, thermal, water vapor permeability, and tensile property features of the obtained material. Increasing the genipin concentration increased the stiffness, tensile strength, and mechanical resistance of the films. Moreover, the swelling decreased and the stability in aqueous media and at high temperature increased after genipin crosslinking [49]. Gelatin microgels were obtained by cooling and crosslinking with genipin of the dispersed gelatin drops [112]. These gels were used to immobilize a β-galactosidase and this was used to deliver the enzyme. These biocatalysts maintained the activity after being freeze-dried. It was stable at 37 °C at neutral and gastric pH values, indicating the suitability of this biocatalyst for solving lactose intolerance [112].

3.3. Enzyme Immobilization without Support Using Genipin to Stabilize the Solid

In this instance, there is not a pre-existing solid where the enzyme is immobilized, but the solid is formed ex-novo during the immobilization of the enzyme [113]. One advantage of these protocols is that they save on support expenses. However, they have also some disadvantages, as a lack of control of the mechanical resistance, high diffusional problems, and not largely significant enzyme stabilization effects [35] except for multimeric enzymes, as they prevent enzyme subunit dissociation [27,114]. Genipin has been employed in some of these strategies; thanks to its high potential as a crosslinker agent, it can be used to produce intermolecular enzyme crosslinking (Figure 11). For example, cross-linked enzyme aggregates (CLEAs) that are biocatalysts formed by the crosslinking of previously aggregated enzymes (by adding some enzyme precipitant reagent) [115,116]. This immobilization method is very simple and has a great popularity, but one of the critical points is the crosslinking step. That way, CLEAs of a lipase were prepared using polyethyleneimine and genipin to get a good crosslinking [117]. This composite was further coated with silica, using the induction caused by the PEI [24]. Immobilization yield was 88% using this strategy [117]. Later, a purified acid urease from Providencia rettgeri JN-B815 was immobilized using the CLEA method using genipin as the crosslinker and bovine serum albumin as the protein feeder [118]. The biocatalyst was applied to remove urea with good reusability (around 80% of the activity was maintained after six reaction cycles). It was applied in rice wine with good elimination of urethane and neither affecting its flavor nor fragrances. The removal rate of urea was still up to 7.56 mg L−1 h−1 and the biocatalyst was re-used six times [118].
The copolymerization of enzymes is an older immobilization strategy, currently not largely utilized due to the difficulties in having reproducible results. In this strategy, the enzyme is mixed with some polymerizing reagent, which forms a solid involving the enzyme in the polymer formation [119,120]. Genipin has been also used to immobilize enzymes using this strategy (Figure 12). That way, it was used to form the solid biocatalysts particles starting from soluble enzymes. Free glucose oxidase and catalase were co-cross-linked using genipin, producing micro copolymerized enzyme biocatalysts [121]. This permitted to accelerate the reaction of the gluconic acid production and the rapid hydrogen peroxide destruction [122]. The reaction rate increased by a 10% during the whole cycle (perhaps due to the oxygen production by the catalase and the concomitant prevention of oxidase inactivation) [121,122].

3.4. Immobilization of Cells Using Genipin

Another application of genipin in the production of biocatalysts is the immobilization of whole cells. However, due to the relative short history of this reagent in biocatalysts design, we have been able to find just one example. S-acetylthio-2-methylpropionic acid was produced using immobilized cells of Pseudomonas fluorescens IFO 12055, using its lipase activity [123]. Standard trapping of the cells in calcium alginate beads offered unsatisfactory results, while the addition of polyethyleneimine and genipin permitted to obtain a stable biocatalyst. It was used for 25 batches maintaining enantiomeric excesses values higher than 90%.

4. Conclusions

After viewing all the applications of genipin on medical and biocatalysts design application, it can be stated that genipin has proved to be a promising crosslinker, with reduced toxicity. Even when most likely all the possibilities of this compound have not been utilized (the genipin mechanism of action is still under debate, the heterofunctionality of the supports is not used), results are usually comparable or even better that those obtained using other common crosslinkers, like glutaraldehyde. In fact, the prices of geniposide, the starting product, are similar to that of genipin. That means that the enzymatic step to hydrolyze this compound is not determining the price. Its extraction from the natural sources or its chemical synthesis may the main responsible for these high prices. Nowadays, applications in medicine (drug, enzymes, and other compounds controlled delivery, tissue scaffolds, etc.) surpass the applications in biocatalysis, as in these applications toxicity is a major issue and price may be present a lower impact in the final price. That makes reduce the demand or a cheaper genipin. Its general use in biocatalyst design, is hitherto limited by the high commercial price that it has compared to its competitors, as in this applications prices of the reactive are more relevant. It may be expected that when its uses expand in this area, a decrease in price will most likely occur and this can facilitate further expansion of the uses of genipin into biocatalyst designs. Nevertheless, the very good results reached in these biomedical applications confirm the high potential of genipin as a crosslinker, and those properties are also key in the design of biocatalysts, mainly to be used in food modification. That way, it is expected that the applications of genipin, both at the industrial and academic level, in the area of biocatalyst design will rapidly increase in the coming years.

Author Contributions

V.G.T.-P., E.G.-P., G.V.-G., J.J.V.-O., Á.B.-M., A.R.A. and R.F.-L. participate in the writing of the draft, R.F.-L. designed the outline of the review, Á.B.-M., A.R.A. and R.F.-L. edited the final manuscript.

Funding

A.B.-M. thanks MICIU (RTI2018-095291-B-I00, MINECO/FEDER) and the Generalitat Valenciana (PROMETEOII/2018/076) for financial support, and R.F.-L. gratefully recognizes the support from MICIU from Spanish Government (project number CTQ2017-86170-R). J.J.V.-O. thanks to CONACYT (Mexico) for the financial support to the basic science project number, CB-2016-01, 286992.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Schoemaker, H.E.; Mink, D.; Wubbolts, M.G. Dispelling the myths-biocatalysis in industrial synthesis. Science 2003, 299, 1694–1697. [Google Scholar] [CrossRef] [PubMed]
  2. Schmid, A.; Dordick, J.S.; Hauer, B.; Kiener, A.; Wubbolts, M.; Witholt, B. Industrial biocatalysis today and tomorrow. Nature 2001, 409, 258. [Google Scholar] [CrossRef] [PubMed]
  3. Pollard, D.J.; Woodley, J.M. Biocatalysis for pharmaceutical intermediates: The future is now. Trends Biotechnol. 2007, 25, 66–73. [Google Scholar] [CrossRef] [PubMed]
  4. Reetz, M.T. Biocatalysis in organic chemistry and biotechnology: Past, present, and future. J. Am. Chem. Soc. 2013, 135, 12480–12496. [Google Scholar] [CrossRef] [PubMed]
  5. Woodley, J.M. New opportunities for biocatalysis: Making pharmaceutical processes greener. Trends Biotechnol. 2008, 26, 321–327. [Google Scholar] [CrossRef]
  6. Robles-Medina, A.; González-Moreno, P.A.; Esteban-Cerdán, L.; Molina-Grima, E. Biocatalysis: Towards ever greener biodiesel production. Biotechnol. Adv. 2009, 27, 398–408. [Google Scholar] [CrossRef]
  7. Patel, R.N. Synthesis of chiral pharmaceutical intermediates by biocatalysis. Coordin. Chem. Rev. 2008, 252, 659–701. [Google Scholar] [CrossRef]
  8. Iyer, P.V.; Ananthanarayan, L. Enzyme stability and stabilization—Aqueous and non-aqueous environment. Process Biochem. 2008, 43, 1019–1032. [Google Scholar] [CrossRef]
  9. Eijsink, V.G.H.; Gåseidnes, S.; Borchert, T.V.; van den Burg, B. Directed evolution of enzyme stability. Biomol. Eng. 2005, 22, 21–30. [Google Scholar] [CrossRef]
  10. Polizzi, K.M.; Bommarius, A.S.; Broering, J.M.; Chaparro-Riggers, J.F. Stability of biocatalysts. Curr. Opin. Chem. Biol. 2007, 11, 220–225. [Google Scholar] [CrossRef]
  11. Castilla, I.A.; Woods, D.F.; Reen, F.J.; O’Gara, F. Harnessing marine biocatalytic reservoirs for green chemistry applications through metagenomic technologies. Mar. Drugs 2018, 16, 227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Peña-García, C.; Martínez-Martínez, M.; Reyes-Duarte, D.; Ferrer, M. High throughput screening of esterases, lipases and phospholipases in mutant and metagenomic libraries: A review. Comb. Chem. High Throughput Screen. 2016, 19, 605–615. [Google Scholar] [CrossRef] [PubMed]
  13. Cowan, D.A.; Ramond, J.-B.; Makhalanyane, T.P.; De Maayer, P. Metagenomics of extreme environments. Curr. Opin. Microbiol. 2015, 25, 97–102. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Fernández-Arrojo, L.; Guazzaroni, M.-E.; López-Cortés, N.; Beloqui, A.; Ferrer, M. Metagenomic era for biocatalyst identification. Curr. Opin. Biotechnol. 2010, 21, 725–733. [Google Scholar] [CrossRef] [PubMed]
  15. Turner, N.J. Directed evolution drives the next generation of biocatalysts. Nat. Chem. Biol. 2009, 5, 567. [Google Scholar] [CrossRef] [PubMed]
  16. Cherry, J.R.; Fidantsef, A.L. Directed evolution of industrial enzymes: An update. Curr. Opin. Biotechnol. 2003, 14, 438–443. [Google Scholar] [CrossRef]
  17. Romero, P.A.; Arnold, F.H. Exploring protein fitness landscapes by directed evolution. Nat. Rev. Mol. Cell Biol. 2009, 10, 866. [Google Scholar] [CrossRef] [Green Version]
  18. Arnold, F.H.; Volkov, A.A. Directed evolution of biocatalysts. Curr. Opin. Chem. Biol. 1999, 3, 54–59. [Google Scholar] [CrossRef]
  19. Boutureira, O.; Bernardes, G.J. Advances in chemical protein modification. Chem. Rev. 2015, 115, 2174–2195. [Google Scholar] [CrossRef]
  20. Cowan, D.A.; Fernandez-Lafuente, R. Enhancing the functional properties of thermophilic enzymes by chemical modification and immobilization. Enzym. Microb. Technol. 2011, 49, 326–346. [Google Scholar] [CrossRef]
  21. Sakamoto, S.; Hamachi, I. Recent progress in chemical modification of proteins. Anal. Sci. 2018, 18R003. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Rodrigues, R.C.; Berenguer-Murcia, Á.; Fernandez-Lafuente, R. Coupling chemical modification and immobilization to improve the catalytic performance of enzymes. Adv. Synth. Catal. 2011, 353, 2216–2238. [Google Scholar] [CrossRef]
  23. Rueda, N.; dos Santos, J.C.S.; Ortiz, C.; Torres, R.; Barbosa, O.; Rodrigues, R.C.; Berenguer-Murcia, Á.; Fernandez-Lafuente, R. Chemical modification in the design of immobilized enzyme biocatalysts: Drawbacks and opportunities. Chem. Rec. 2016, 16, 1436–1455. [Google Scholar] [CrossRef] [PubMed]
  24. Virgen-Ortíz, J.J.; dos Santos, J.C.S.; Berenguer-Murcia, Á.; Barbosa, O.; Rodrigues, R.C.; Fernandez-Lafuente, R. Polyethylenimine: A very useful ionic polymer in the design of immobilized enzyme biocatalysts. J. Mater. Chem. B 2017, 5, 7461–7490. [Google Scholar] [CrossRef] [Green Version]
  25. Fernandez-Lopez, L.; Virgen-OrtÍz, J.J.; Pedrero, S.G.; Lopez-Carrobles, N.; Gorines, B.C.; Otero, C.; Fernandez-Lafuente, R. Optimization of the coating of octyl-CALB with ionic polymers to improve stability and decrease enzyme leakage. Biocatal. Biotransformation 2018, 36, 47–56. [Google Scholar] [CrossRef]
  26. Fernandez-Lopez, L.; Pedrero, S.G.; Lopez-Carrobles, N.; Virgen-Ortíz, J.J.; Gorines, B.C.; Otero, C.; Fernandez-Lafuente, R. Physical crosslinking of lipase from Rhizomucor miehei immobilized on octyl agarose via coating with ionic polymers: Avoiding enzyme release from the support. Process Biochem. 2017, 54, 81–88. [Google Scholar] [CrossRef]
  27. Fernandez-Lafuente, R. Stabilization of multimeric enzymes: Strategies to prevent subunit dissociation. Enzym. Microb. Technol. 2009, 45, 405–418. [Google Scholar] [CrossRef]
  28. Sheldon, R.A.; van Pelt, S. Enzyme immobilisation in biocatalysis: Why, what and how. Chem. Soc. Rev. 2013, 42, 6223–6235. [Google Scholar] [CrossRef] [Green Version]
  29. Zdarta, J.; Meyer, A.S.; Jesionowski, T.; Pinelo, M. A general overview of support materials for enzyme immobilization: Characteristics, properties, practical utility. Catalysts 2018, 8, 92. [Google Scholar] [CrossRef] [Green Version]
  30. Dos Santos, J.C.S.; Rueda, N.; Barbosa, O.; Fernández-Sánchez, J.F.; Medina-Castillo, A.L.; Ramón-Márquez, T.; Arias-Martos, M.C.; Millán-Linares, M.C.; Pedroche, J.; del Mar Yust, M. Characterization of supports activated with divinyl sulfone as a tool to immobilize and stabilize enzymes via multipoint covalent attachment. Application to chymotrypsin. RSC Adv. 2015, 5, 20639–20649. [Google Scholar] [CrossRef] [Green Version]
  31. Mateo, C.; Palomo, J.M.; Fernandez-Lorente, G.; Guisan, J.M.; Fernandez-Lafuente, R. Improvement of enzyme activity, stability and selectivity via immobilization techniques. Enzym. Microb. Technol. 2007, 40, 1451–1463. [Google Scholar] [CrossRef]
  32. Sheldon, R.A. Enzyme immobilization: The quest for optimum performance. Adv. Synth. Catal. 2007, 349, 1289–1307. [Google Scholar] [CrossRef]
  33. Singh, R.K.; Tiwari, M.K.; Singh, R.; Lee, J.-K. From protein engineering to immobilization: Promising strategies for the upgrade of industrial enzymes. Int. J. Mol. Sci. 2013, 14, 1232–1277. [Google Scholar] [CrossRef] [PubMed]
  34. Rodrigues, R.C.; Ortiz, C.; Berenguer-Murcia, A.; Torres, R.; Fernandez-Lafuente, R. Modifying enzyme activity and selectivity by immobilization. Chem. Soc. Rev. 2013, 42, 6290–6307. [Google Scholar] [CrossRef] [PubMed]
  35. Garcia-Galan, C.; Berenguer-Murcia, Á.; Fernandez-Lafuente, R.; Rodrigues, R.C. Potential of different enzyme immobilization strategies to improve enzyme performance. Adv. Synth. Catal. 2011, 353, 2885–2904. [Google Scholar] [CrossRef]
  36. Rodrigues, R.C.; Virgen-Ortíz, J.J.; dos Santos, J.C.S.; Berenguer-Murcia, Á.; Alcantara, A.R.; Barbosa, O.; Ortiz, C.; Fernandez-Lafuente, R. Immobilization of lipases on hydrophobic supports: Immobilization mechanism, advantages, problems, and solutions. Biotechnol. Adv. 2019, 37, 746–770. [Google Scholar] [CrossRef] [Green Version]
  37. Brady, D.; Jordaan, J. Advances in enzyme immobilisation. Biotechnol. Lett. 2009, 31, 1639. [Google Scholar] [CrossRef]
  38. Tran, D.N.; Balkus, K.J., Jr. Perspective of recent progress in immobilization of enzymes. ACS Catal. 2011, 1, 956–968. [Google Scholar] [CrossRef]
  39. Mohamad, N.R.; Marzuki, N.H.C.; Buang, N.A.; Huyop, F.; Wahab, R.A. An overview of technologies for immobilization of enzymes and surface analysis techniques for immobilized enzymes. Biotechnol. Biotechnol. Eq. 2015, 29, 205–220. [Google Scholar] [CrossRef]
  40. Homaei, A.A.; Sariri, R.; Vianello, F.; Stevanato, R. Enzyme immobilization: An update. J. Chem. Biol. 2013, 6, 185–205. [Google Scholar] [CrossRef] [Green Version]
  41. Virgen-Ortíz, J.J.; dos Santos, J.C.S.; Ortiz, C.; Berenguer-Murcia, Á.; Barbosa, O.; Rodrigues, R.C.; Fernandez-Lafuente, R. Lecitase ultra: A phospholipase with great potential in biocatalysis. Mol. Catal. 2019, 473, 110405. [Google Scholar] [CrossRef] [Green Version]
  42. Barbosa, O.; Ortiz, C.; Berenguer-Murcia, Á.; Torres, R.; Rodrigues, R.C.; Fernandez-Lafuente, R. Strategies for the one-step immobilization-purification of enzymes as industrial biocatalysts. Biotechnol. Adv. 2015, 33, 435–456. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Rodrigues, R.C.; Barbosa, O.; Ortiz, C.; Berenguer-Murcia, Á.; Torres, R.; Fernandez-Lafuente, R. Amination of enzymes to improve biocatalyst performance: Coupling genetic modification and physicochemical tools. RSC Adv. 2014, 4, 38350–38374. [Google Scholar] [CrossRef] [Green Version]
  44. López-Gallego, F.; Montes, T.; Fuentes, M.; Alonso, N.; Grazu, V.; Betancor, L.; Guisán, J.M.; Fernández-Lafuente, R. Improved stabilization of chemically aminated enzymes via multipoint covalent attachment on glyoxyl supports. J. Biotechnol. 2005, 116, 1–10. [Google Scholar] [CrossRef] [PubMed]
  45. Rueda, N.; dos Santos, J.C.S.; Torres, R.; Ortiz, C.; Barbosa, O.; Fernandez-Lafuente, R. Improved performance of lipases immobilized on heterofunctional octyl-glyoxyl agarose beads. RSC Adv. 2015, 5, 11212–11222. [Google Scholar] [CrossRef] [Green Version]
  46. Rios, N.S.; Mendez-Sanchez, C.; Arana-Peña, S.; Rueda, N.; Ortiz, C.; Gonçalves, L.R.B.; Fernandez-Lafuente, R. Immobilization of lipase from Pseudomonas fluorescens on glyoxyl-octyl-agarose beads: Improved stability and reusability. Biochim. Biophys. Acta BBA Proteins Proteom. 2019, 1867, 741–747. [Google Scholar] [CrossRef] [PubMed]
  47. Gk, M.S.; Rounaghi, G.H.; Chamsaz, M. An optical sensor for determination of low pH values based on covalent immobilization of Congo red on triacetyl cellulose films via epichlorohydrin. Sensors Actuat. B Chem. 2018, 254, 177–181. [Google Scholar]
  48. Santos, J.C.; Paula, A.V.; Nunes, G.F.M.; De Castro, H.F. Pseudomonas fluorescens lipase immobilization on polysiloxane–polyvinyl alcohol composite chemically modified with epichlorohydrin. J. Mol. Catal. B Enzym. 2008, 52, 49–57. [Google Scholar] [CrossRef]
  49. Zhang, D.-H.; Peng, L.-J.; Wang, Y.; Li, Y.-Q. Lipase immobilization on epoxy-activated poly (vinyl acetate-acrylamide) microspheres. Colloid Surf. B 2015, 129, 206–210. [Google Scholar] [CrossRef]
  50. Rios, N.S.; Neto, D.M.A.; dos Santos, J.C.S.; Fechine, P.B.A.; Fernández-Lafuente, R.; Gonçalves, L.R.B. Comparison of the immobilization of lipase from Pseudomonas fluorescens on divinylsulfone or p-benzoquinone activated support. Int. J. Biol. Macromol. 2019, 134, 936–945. [Google Scholar] [CrossRef]
  51. Dos Santos, J.C.S.; Rueda, N.; Sanchez, A.; Villalonga, R.; Gonçalves, L.R.B.; Fernandez-Lafuente, R. Versatility of divinylsulfone supports permits the tuning of CALB properties during its immobilization. RSC Adv. 2015, 5, 35801–35810. [Google Scholar] [CrossRef]
  52. Pinheiro, B.B.; Rios, N.S.; Aguado, E.R.; Fernandez-Lafuente, R.; Freire, T.M.; Fechine, P.B.A.; dos Santos, J.C.S.; Gonçalves, L.R.B. Chitosan activated with divinyl sulfone: A new heterofunctional support for enzyme immobilization. Application in the immobilization of lipase B from Candida antarctica. Int. J. Biol. Macromol. 2019, 130, 798–809. [Google Scholar] [CrossRef] [PubMed]
  53. Barbosa, O.; Ortiz, C.; Berenguer-Murcia, Á.; Torres, R.; Rodrigues, R.C.; Fernandez-Lafuente, R. Glutaraldehyde in bio-catalysts design: A useful crosslinker and a versatile tool in enzyme immobilization. RSC Adv. 2014, 4, 1583–1600. [Google Scholar] [CrossRef] [Green Version]
  54. Fernandez-Lafuente, R.; Rosell, C.M.; Rodriguez, V.; Guisan, J.M. Strategies for enzyme stabilization by intramolecular crosslinking with bifunctional reagents. Enzym. Microb. Technol. 1995, 17, 517–523. [Google Scholar] [CrossRef]
  55. Siar, E.-H.; Arana-Peña, S.; Barbosa, O.; Zidoune, M.N.; Fernandez-Lafuente, R. Solid phase chemical modification of agarose glyoxyl-ficin: Improving activity and stability properties by amination and modification with glutaraldehyde. Process. Biochem. 2018, 73, 109–116. [Google Scholar] [CrossRef]
  56. Migneault, I.; Dartiguenave, C.; Bertrand, M.J.; Waldron, K.C. Glutaraldehyde: Behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking. Biotechniques 2004, 37, 790–802. [Google Scholar] [CrossRef] [PubMed]
  57. Kowal, R.; Parsons, R.G. Stabilization of proteins immobilized on Sepharose from leakage by glutaraldehyde crosslinking. Anal. Biochem. 1980, 102, 72–76. [Google Scholar] [CrossRef]
  58. Zaak, H.; Fernandez-Lopez, L.; Otero, C.; Sassi, M.; Fernandez-Lafuente, R. Improved stability of immobilized lipases via modification with polyethylenimine and glutaraldehyde. Enzym. Microb. Technol. 2017, 106, 67–74. [Google Scholar] [CrossRef]
  59. López-Gallego, F.; Betancor, L.; Mateo, C.; Hidalgo, A.; Alonso-Morales, N.; Dellamora-Ortiz, G.; Guisán, J.M.; Fernández-Lafuente, R. Enzyme stabilization by glutaraldehyde crosslinking of adsorbed proteins on aminated supports. J. Biotechnol. 2005, 119, 70–75. [Google Scholar] [CrossRef]
  60. Liu, X.; Lou, H. Synthesis of monoterpene alkaloid derivatives from the iridoid glucoside geniposide. Nat. Prod. Res. 2007, 21, 1157–1164. [Google Scholar] [CrossRef]
  61. Isoe, S.; Katsumura, S.; Okada, T.; Yamamoto, K.; Takemoto, T.; Inaba, H.; Han, Q.; Nakatani, K. Novel synthesis of (−)-Secologanin aglucon-O-silyl ether from (+)-genipin via oxidative fragmentation of γ-hydroxyalkylstannane. Tetrahedron Lett. 1987, 28, 5865–5868. [Google Scholar] [CrossRef]
  62. Samprasit, W.; Akkaramongkolporn, P.; Jaewjira, S.; Opanasopit, P. Design of alpha mangostin-loaded chitosan/alginate controlled-release nanoparticles using genipin as crosslinker. J. Drug Deliv. Sci. Technol. 2018, 46, 312–321. [Google Scholar] [CrossRef]
  63. Chronopoulou, L.; Daniele, M.; Perez, V.; Gentili, A.; Gasperi, T.; Lupi, S.; Palocci, C. A physico-chemical approach to the study of genipin crosslinking of biofabricated peptide hydrogels. Process. Biochem. 2018, 70, 110–116. [Google Scholar] [CrossRef]
  64. Somers, P.; De Somer, F.; Cornelissen, M.; Bouchez, S.; Gasthuys, F.; Narine, K.; Cox, E.; Van Nooten, G. Genipin blues: An alternative non-toxic crosslinker for heart valves? J. Heart Valve Dis. 2008, 17, 682. [Google Scholar] [PubMed]
  65. Tsai, C.C.; Huang, R.N.; Sung, H.W.; Liang, H.C. In vitro evaluation of the genotoxicity of a naturally occurring crosslinking agent (genipin) for biologic tissue fixation. J. Biomed. Mater. Res. 2000, 52, 58–65. [Google Scholar] [CrossRef]
  66. Roether, J.; Oelschlaeger, C.; Willenbacher, N. Hyaluronic acid cryogels with non-cytotoxic crosslinker genipin. Mater. Lett. 2019, 4, 100027. [Google Scholar] [CrossRef]
  67. Manickam, B.; Sreedharan, R.; Elumalai, M. ‘Genipin’—The natural water soluble cross-linking agent and its importance in the modified drug delivery systems: An overview. Curr. Drug Deliv. 2014, 11, 139–145. [Google Scholar] [CrossRef]
  68. Di Tommaso, S.; David, P.; Picolet, K.; Gabant, M.; David, H.; Morançais, J.-L.; Gomar, J.; Leroy, F.; Adamo, C. Structure of genipin in solution: A combined experimental and theoretical study. RSC Adv. 2013, 3, 13764–13771. [Google Scholar] [CrossRef]
  69. Di Tommaso, S.; David, H.; Gomar, J.; Leroy, F.; Adamo, C. From iridoids to dyes: A theoretical study on genipin reactivity. RSC Adv. 2014, 4, 11029–11038. [Google Scholar] [CrossRef]
  70. Trevor, S.L.; Butler, M.F.; Adams, S.; Laity, P.R.; Burley, J.C.; Cameron, R.E. Structure and phase transitions of genipin, an herbal medicine and naturally occurring cross-linker. Cryst. Growth Des. 2008, 8, 1748–1753. [Google Scholar] [CrossRef] [Green Version]
  71. Fujikawa, S.; Nakamura, S.; Koga, K. Genipin, a new type of protein crosslinking reagent from gardenia fruits. Agric. Biol. Chem. 1988, 52, 869–870. [Google Scholar]
  72. Neri-Numa, I.A.; Pessoa, M.G.; Paulino, B.N.; Pastore, G.M. Genipin: A natural blue pigment for food and health purposes. Trends Food Sci. Technol. 2017, 67, 271–279. [Google Scholar] [CrossRef]
  73. Butler, M.F.; Ng, Y.F.; Pudney, P.D.A. Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin. J. Polym. Sci. Pol. Chem. 2003, 41, 3941–3953. [Google Scholar] [CrossRef]
  74. Touyama, R.; Inoue, K.; Takeda, Y.; Yatsuzuka, M.; Ikumoto, T.; Moritome, N.; Shingu, T.; Yokoi, T.; Inouye, H. Studies on the blue pigments produced from genipin and methylamine. II. On the formation mechanisms of brownish-red intermediates leading to the blue pigment formation. Chem. Pharm. Bull. 1994, 42, 1571–1578. [Google Scholar] [CrossRef] [Green Version]
  75. Dimida, S.; Demitri, C.; De Benedictis, V.M.; Scalera, F.; Gervaso, F.; Sannino, A. Genipin-cross-linked chitosan-based hydrogels: Reaction kinetics and structure-related characteristics. J. Appl. Polym. Sci. 2015, 132, 42256. [Google Scholar] [CrossRef]
  76. Pujana, M.A.; Pérez-Álvarez, L.; Iturbe, L.C.C.; Katime, I. Biodegradable chitosan nanogels crosslinked with genipin. Carbohyd. Polym. 2013, 94, 836–842. [Google Scholar] [CrossRef]
  77. Muzzarelli, R.A.A.; El Mehtedi, M.; Bottegoni, C.; Aquili, A.; Gigante, A. Genipin-crosslinked chitosan gels and scaffolds for tissue engineering and regeneration of cartilage and bone. Mar. Drugs 2015, 13, 7314–7338. [Google Scholar] [CrossRef] [Green Version]
  78. Fujikawa, S.; Fukui, Y.; Koga, K.; Iwashita, T.; Komura, H.; Nomoto, K. Structure of genipocyanin G1, a spontaneous reaction product between genipin and glycine. Tetrahedron Lett. 1987, 28, 4699–4700. [Google Scholar] [CrossRef]
  79. Yoo, J.S.; Kim, Y.J.; Kim, S.H.; Choi, S.H. Study on genipin: A new alternative natural crosslinking agent for fixing heterograft tissue. Korean J. Thorac. Cardiovasc. Surg. 2011, 44, 197–207. [Google Scholar] [CrossRef]
  80. Sung, H.W.; Chang, Y.; Liang, I.L.; Chang, W.H.; Chen, Y.C. Fixation of biological tissues with a naturally occurring crosslinking agent: Fixation rate and effects of pH, temperature, and initial fixative concentration. J. Biomed. Mater. Res. 2000, 52, 77–87. [Google Scholar] [CrossRef]
  81. Chang, Y.; Tsai, C.-C.; Liang, H.-C.; Sung, H.-W. Reconstruction of the right ventricular outflow tract with a bovine jugular vein graft fixed with a naturally occurring crosslinking agent (genipin) in a canine model. J. Thorac. Cardiovasc. 2001, 122, 1208–1218. [Google Scholar] [CrossRef] [PubMed]
  82. Kanungo, I.; Fathima, N.N.; Jonnalagadda, R.R.; Nair, B.U. Elucidation of hydration dynamics of locust bean gum-collagen composites by impedance and thermoporometry. Carbohydr. Polym. 2014, 103, 250–260. [Google Scholar] [CrossRef] [PubMed]
  83. Touyama, R.; Takeda, Y.; Inoue, K.; Kawamura, I.; Yatsuzuka, M.; Ikumoto, T.; Shingu, T.; Yokoi, T.; Inouye, H. Studies on the blue pigments produced from genipin and methylamine. I. Structures of the brownish-red pigments, intermediates leading to the blue pigments. Chem. Pharm. Bull. 1994, 42, 668–673. [Google Scholar] [CrossRef] [Green Version]
  84. Oryan, A.; Kamali, A.; Moshiri, A.; Baharvand, H.; Daemi, H. Chemical crosslinking of biopolymeric scaffolds: Current knowledge and future directions of crosslinked engineered bone scaffolds. Int. J. Biol. Macromol. 2018, 107, 678–688. [Google Scholar] [CrossRef]
  85. Liu, J.; Liu, C.; Brown, E.M.; Keyong, T. Characterization and thermal properties of polygenipin-crosslinked hide powders. J. Am. Leather Chem. Assoc. 2018, 113, 96–104. [Google Scholar]
  86. Dai, Y.; Zhang, X. Stable and biocompatible genipin-inducing interlayer-crosslinked micelles for sustained drug release. J. Nanopart. Res. 2017, 19, 164. [Google Scholar] [CrossRef]
  87. Reddy, N.; Reddy, R.; Jiang, Q. Crosslinking biopolymers for biomedical applications. Trends Biotechnol. 2015, 33, 362–369. [Google Scholar] [CrossRef]
  88. Ma, H.-F.; Meng, G.; Cui, B.-K.; Si, J.; Dai, Y.-C. Chitosan crosslinked with genipin as supporting matrix for biodegradation of synthetic dyes: Laccase immobilization and characterization. Chem. Eng. Res. Des. 2018, 132, 664–676. [Google Scholar] [CrossRef]
  89. Flores, E.E.E.; Cardoso, F.D.; Siqueira, L.B.; Ricardi, N.C.; Costa, T.H.; Rodrigues, R.C.; Klein, M.P.; Hertz, P.F. Influence of reaction parameters in the polymerization between genipin and chitosan for enzyme immobilization. Process. Biochem. 2019, 84, 73–80. [Google Scholar] [CrossRef]
  90. Barbosa, O.; Torres, R.; Ortiz, C.; Berenguer-Murcia, A.; Rodrigues, R.C.; Fernandez-Lafuente, R. Heterofunctional supports in enzyme immobilization: From traditional immobilization protocols to opportunities in tuning enzyme properties. Biomacromolecules 2013, 14, 2433–2462. [Google Scholar] [CrossRef] [Green Version]
  91. Fujikawa, S.; Yokota, T.; Koga, K. Immobilization of β-glucosidase in calcium alginate gel using genipin as a new type of cross-linking reagent of natural origin. Appl. Microbiol. Biotechnol. 1988, 28, 440–441. [Google Scholar] [CrossRef]
  92. Wang, W.; Jiang, Y.; Zhou, L.; Gao, J. Comparison of the properties of lipase immobilized onto mesoporous resins by different methods. Appl. Biochem. Biotechnol. 2011, 164, 561–572. [Google Scholar] [CrossRef]
  93. Krajewska, B. Application of chitin-and chitosan-based materials for enzyme immobilizations: A review. Enzym. Microb. Technol. 2004, 35, 126–139. [Google Scholar] [CrossRef]
  94. Chiou, S.H.; Hung, T.C.; Giridhar, R.; Wu, W.T. Immobilization of lipase to chitosan beads using a natural cross-linker. Prep. Biochem Biotechnol. 2007, 37, 265–275. [Google Scholar] [CrossRef]
  95. Gracida, J.; Arredondo-Ochoa, T.; García-Almendárez, B.E.; Escamilla-García, M.; Shirai, K.; Regalado, C.; Amaro-Reyes, A. Improved Thermal and Reusability Properties of Xylanase by Genipin Cross-Linking to Magnetic Chitosan Particles. Appl. Biochem. Biotechnol. 2019, 188, 395–409. [Google Scholar] [CrossRef]
  96. Fernandes, S.C.; de Oliveira Santos, D.M.P.; Vieira, I.C. Genipin-cross-linked chitosan as a support for laccase biosensor. Electroanalysis 2013, 25, 557–566. [Google Scholar] [CrossRef]
  97. Rangel-Rodríguez, A.M.; Conxita, S.; Susana, V.; Flores-Gallardo, S.G.; Contreras-Esquivel, J.C.; Licea-Jiménez, L. Immobilization of pectinesterase in genipin-crosslinked chitosan membrane for low methoxyl pectin production. Appl. Biochem. Biotechnol. 2014, 174, 2941–2950. [Google Scholar] [CrossRef]
  98. Klein, M.P.; Hackenhaar, C.R.; Lorenzoni, A.S.G.; Rodrigues, R.C.; Costa, T.M.H.; Ninow, J.L.; Hertz, P.F. Chitosan crosslinked with genipin as support matrix for application in food process: Support characterization and β-d-galactosidase immobilization. Carbohydr. Polym. 2016, 137, 184–190. [Google Scholar] [CrossRef] [Green Version]
  99. Cavello, I.A.; Contreras-Esquivel, J.C.; Cavalitto, S.F. Immobilization of a keratinolytic protease from Purpureocillium lilacinum on genipin activated-chitosan beads. Process. Biochem. 2014, 49, 1332–1336. [Google Scholar] [CrossRef]
  100. Liu, Y.; Zhou, H.; Wang, L.; Wang, S. Stability and catalytic properties of lipase immobilized on chitosan encapsulated magnetic nanoparticles cross-linked with genipin and glutaraldehyde. J. Chem. Technol. Biotechnol. 2016, 91, 1359–1367. [Google Scholar] [CrossRef]
  101. Phadungcharoen, N.; Winotapun, W.; Khomniyawanit, A.; Krataichan, F.; Rojanarata, T. Facile and green fabrication of biocatalytic chitosan beads by one-step genipin-mediated β-glucosidase immobilization for production of bioactive genistein. Sustain. Chem. Pharm. 2019, 14, 100187. [Google Scholar] [CrossRef]
  102. Salazar-Leyva, J.A.; Lizardi-Mendoza, J.; Ramirez-Suarez, J.C.; Valenzuela-Soto, E.M.; Ezquerra-Brauer, J.M.; Castillo-Yañez, F.J.; Pacheco-Aguilar, R. Acidic proteases from Monterey sardine (Sardinops sagax caerulea) immobilized on shrimp waste chitin and chitosan supports: Searching for a by-product catalytic system. Appl. Biochem. Biotechnol. 2013, 171, 795–805. [Google Scholar] [CrossRef]
  103. Metin, A.Ü. Immobilization of laccase onto polyethyleneimine grafted chitosan films: Effect of system parameters. Macromol. Res. 2013, 21, 1145–1152. [Google Scholar] [CrossRef]
  104. Dai, Q.; Ma, Y.; Wang, S.; Kankala, R.K.; Liu, Y. Investigation of various cross-linking methods for the immobilization of cytosine arabinoside on bacterial magnetosomes. J. Nanomater. 2017, 2017, 6738484. [Google Scholar] [CrossRef]
  105. Barbosa, O.; Torres, R.; Ortiz, C.; Fernandez-Lafuente, R. Versatility of glutaraldehyde to immobilize lipases: Effect of the immobilization protocol on the properties of lipase B from Candida antarctica. Process. Biochem. 2012, 47, 1220–1227. [Google Scholar] [CrossRef]
  106. Vazquez-Ortega, P.G.; Alcaraz-Fructuoso, M.T.; Rojas-Contreras, J.A.; López-Miranda, J.; Fernandez-Lafuente, R. Stabilization of dimeric β-glucosidase from Aspergillus niger via glutaraldehyde immobilization under different conditions. Enzym. Microb. Technol. 2018, 110, 38–45. [Google Scholar] [CrossRef]
  107. Zaak, H.; Peirce, S.; de Albuquerque, T.; Sassi, M.; Fernandez-Lafuente, R. Exploiting the versatility of aminated supports activated with glutaraldehyde to immobilize β-galactosidase from Aspergillus oryzae. Catalysts 2017, 7, 250. [Google Scholar] [CrossRef] [Green Version]
  108. Siar, E.-H.; Arana-Peña, S.; Barbosa, O.; Zidoune, M.; Fernandez-Lafuente, R. Immobilization/stabilization of ficin extract on glutaraldehyde-activated agarose beads. Variables that control the final stability and activity in protein hydrolyses. Catalysts 2018, 8, 149. [Google Scholar] [CrossRef] [Green Version]
  109. De Andrades, D.; Graebin, N.G.; Kadowaki, M.K.; Ayub, M.A.Z.; Fernandez-Lafuente, R.; Rodrigues, R.C. Immobilization and stabilization of different β-glucosidases using the glutaraldehyde chemistry: Optimal protocol depends on the enzyme. Int. J. Biol. Macromol. 2019, 129, 672–678. [Google Scholar] [CrossRef]
  110. Yang, Q.; Lan, F.; Liu, Z.; Ma, S.; Li, W.; Wu, Y.; Gu, Z. Uniform Superparamagnetic Fe3O4/CMCS Composite Nanospheres for Lysozyme Adsorption. J. Nanosci. Nanotechnol. 2016, 16, 2233–2238. [Google Scholar] [CrossRef]
  111. Ma, W.; Tang, C.-H.; Yin, S.-W.; Yang, X.-Q.; Qi, J.-R. Genipin-crosslinked gelatin films as controlled releasing carriers of lysozyme. Food Res. Int. 2013, 51, 321–324. [Google Scholar] [CrossRef]
  112. Beldengruün, Y.; Aragon, J.; Prazeres, S.F.; Montalvo, G.; Miras, J.; Esquena, J. Gelatin/Maltodextrin Water-in-Water (W/W) emulsions for the preparation of Cross-Linked Enzyme-Loaded microgels. Langmuir 2018, 34, 9731–9743. [Google Scholar] [CrossRef]
  113. Cao, L.; van Langen, L.; Sheldon, R.A. Immobilised enzymes: Carrier-bound or carrier-free? Curr. Opin. Biotechnol. 2003, 14, 387–394. [Google Scholar] [CrossRef]
  114. Wilson, L.; Betancor, L.; Fernández-Lorente, G.; Fuentes, M.; Hidalgo, A.; Guisán, J.M.; Pessela, B.C.C.; Fernández-Lafuente, R. Cross-linked aggregates of multimeric enzymes: A simple and efficient methodology to stabilize their quaternary structure. Biomacromolecules 2004, 5, 814–817. [Google Scholar] [CrossRef]
  115. Cao, L.; van Rantwijk, F.; Sheldon, R.A. Cross-linked enzyme aggregates: A simple and effective method for the immobilization of penicillin acylase. Org. Lett. 2000, 2, 1361–1364. [Google Scholar] [CrossRef]
  116. Cao, L.; Van Langen, L.M.; Van Rantwijk, F.; Sheldon, R.A. Cross-linked aggregates of penicillin acylase: Robust catalysts for the synthesis of β-lactam antibiotics. J. Mol. Catal. B Enzym. 2001, 11, 665–670. [Google Scholar] [CrossRef]
  117. Yanjun, J.; Qi, W.; Wenqin, W.; Liya, Z.; Jing, G. Preparation of immobilized lipase through combination of cross-linked enzyme aggregates and biomimetic silicification. Chin. J. Catal. 2012, 33, 857–862. [Google Scholar]
  118. Zhang, Q.; Zha, X.; Zhou, N.; Tian, Y. Preparation of crosslinked enzyme aggregates (CLEAs) of acid urease with urethanase activity and their application. J. Basic Microb. 2016, 56, 422–431. [Google Scholar] [CrossRef]
  119. Müller, F.; Torger, B.; Allertz, P.J.; Jähnichen, K.; Keßler, S.; Müller, M.; Simon, F.; Salchert, K.; Mäurer, H.; Pospiech, D. Multifunctional crosslinkable itaconic acid copolymers for enzyme immobilization. Eur. Polym. J. 2018, 102, 47–55. [Google Scholar] [CrossRef]
  120. Pollak, A.; Blumenfeld, H.; Wax, M.; Baughn, R.L.; Whitesides, G.M. Enzyme immobilization by condensation copolymerization into crosslinked polyacrylamide gels. J. Am. Chem. Soc. 1980, 102, 6324–6336. [Google Scholar] [CrossRef]
  121. Cui, C.; Chen, H.; Chen, B.; Tan, T. Genipin cross-linked glucose oxidase and catalase multi-enzyme for gluconic acid synthesis. Appl. Biochem. Biotechnol. 2017, 181, 526–535. [Google Scholar] [CrossRef]
  122. Hernandez, K.; Berenguer-Murcia, A.; Rodrigues, R.C.; Fernandez-Lafuente, R. Hydrogen peroxide in biocatalysis. A dangerous liaison. Curr. Org. Chem. 2012, 16, 2652–2672. [Google Scholar] [CrossRef]
  123. Ko, C.-S.; Chu, I.M. Immobilized cells biocatalyst for the production of S-acetylthio-2-methyl propionic acid. Enzyme Microb. Technol. 2004, 35, 619–623. [Google Scholar] [CrossRef]
Figure 1. Hydrolysis of geniposide for the production of genipin.
Figure 1. Hydrolysis of geniposide for the production of genipin.
Catalysts 09 01035 g001
Figure 2. Different chemical structures to obtain genipin.
Figure 2. Different chemical structures to obtain genipin.
Catalysts 09 01035 g002
Figure 3. Mechanism for the opening of hemiacetal 1 to yield dialdehyde 4.
Figure 3. Mechanism for the opening of hemiacetal 1 to yield dialdehyde 4.
Catalysts 09 01035 g003
Figure 4. Different transition states in the opening of hemiacetal 1, with or without the involvement of one or two water molecules.
Figure 4. Different transition states in the opening of hemiacetal 1, with or without the involvement of one or two water molecules.
Catalysts 09 01035 g004
Figure 5. Possible mechanism for the crosslinking of amine-containing biopolymers with genipin, according to Butler et al. [73].
Figure 5. Possible mechanism for the crosslinking of amine-containing biopolymers with genipin, according to Butler et al. [73].
Catalysts 09 01035 g005
Figure 6. (a) Structure of genipocyanin G1, according to Fujikawa et al. [71,78]; (b) proposed crosslinked structure; (c) dimerization products of genipin, as reported by Touyama et al. [74,83].
Figure 6. (a) Structure of genipocyanin G1, according to Fujikawa et al. [71,78]; (b) proposed crosslinked structure; (c) dimerization products of genipin, as reported by Touyama et al. [74,83].
Catalysts 09 01035 g006
Figure 7. Aminated supports activated with genipin: a heterofunctional support.
Figure 7. Aminated supports activated with genipin: a heterofunctional support.
Catalysts 09 01035 g007
Figure 8. Enzyme immobilization by activation of aminated supports with genipin.
Figure 8. Enzyme immobilization by activation of aminated supports with genipin.
Catalysts 09 01035 g008
Figure 9. Crosslinking of enzymes immobilized on aminated supports by crosslinking with genipin.
Figure 9. Crosslinking of enzymes immobilized on aminated supports by crosslinking with genipin.
Catalysts 09 01035 g009
Figure 10. One step immobilization of enzymes on aminated supports using genipin.
Figure 10. One step immobilization of enzymes on aminated supports using genipin.
Catalysts 09 01035 g010
Figure 11. Cross-linked enzyme aggregates (CLEAs) with genipin.
Figure 11. Cross-linked enzyme aggregates (CLEAs) with genipin.
Catalysts 09 01035 g011
Figure 12. Copolymerized enzyme biocatalyst crosslinked using genipin.
Figure 12. Copolymerized enzyme biocatalyst crosslinked using genipin.
Catalysts 09 01035 g012

Share and Cite

MDPI and ACS Style

Tacias-Pascacio, V.G.; García-Parra, E.; Vela-Gutiérrez, G.; Virgen-Ortiz, J.J.; Berenguer-Murcia, Á.; Alcántara, A.R.; Fernandez-Lafuente, R. Genipin as An Emergent Tool in the Design of Biocatalysts: Mechanism of Reaction and Applications. Catalysts 2019, 9, 1035. https://0-doi-org.brum.beds.ac.uk/10.3390/catal9121035

AMA Style

Tacias-Pascacio VG, García-Parra E, Vela-Gutiérrez G, Virgen-Ortiz JJ, Berenguer-Murcia Á, Alcántara AR, Fernandez-Lafuente R. Genipin as An Emergent Tool in the Design of Biocatalysts: Mechanism of Reaction and Applications. Catalysts. 2019; 9(12):1035. https://0-doi-org.brum.beds.ac.uk/10.3390/catal9121035

Chicago/Turabian Style

Tacias-Pascacio, Veymar G., Esmeralda García-Parra, Gilber Vela-Gutiérrez, Jose J. Virgen-Ortiz, Ángel Berenguer-Murcia, Andrés R. Alcántara, and Roberto Fernandez-Lafuente. 2019. "Genipin as An Emergent Tool in the Design of Biocatalysts: Mechanism of Reaction and Applications" Catalysts 9, no. 12: 1035. https://0-doi-org.brum.beds.ac.uk/10.3390/catal9121035

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop